New Leaders Council

• Define and execute the company's strategy, aligning science, operations, and business goals
• Lead seed and Series A fundraising, leveraging networks and partnerships to secure capital and strategic collaborations
• Choose and prioritize indication strategy, such as DKD, obesity, atherosclerosis, or MASH, based on opportunity, patient need, and risk
• Oversee the transition from preclinical development to IND submission and clinical development
• Build and manage the team as the company progresses
• Collaborate with Professor Ann Marie Schmidt and advisors to integrate scientific excellence with commercial strategy
• Represent the venture to investors, partners, and the scientific community
• Lead all aspects of the venture's growth from strategy-setting through advancing programs into clinical trials

Co-Founding CEO – Metabolic & Inflammation Therapies